388 related articles for article (PubMed ID: 34065546)
1. Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine.
Mollinedo F; Gajate C
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065546
[TBL] [Abstract][Full Text] [Related]
2. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
3. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.
Mollinedo F; Fernández M; Hornillos V; Delgado J; Amat-Guerri F; Acuña AU; Nieto-Miguel T; Villa-Pulgarín JA; González-García C; Ceña V; Gajate C
Cell Death Dis; 2011 May; 2(5):e158. PubMed ID: 21593790
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
5. Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosine.
Alonso-Pérez V; Hernández V; Calzado MA; Vicente-Blázquez A; Gajate C; Soler-Torronteras R; DeCicco-Skinner K; Sierra A; Mollinedo F
Biomed Pharmacother; 2024 Feb; 171():116149. PubMed ID: 38266621
[TBL] [Abstract][Full Text] [Related]
6. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
7. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
Gajate C; Mollinedo F
J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
[TBL] [Abstract][Full Text] [Related]
8. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
9. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer.
Mollinedo F; Gajate C
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439330
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine.
Bonilla X; Dakir el-H; Mollinedo F; Gajate C
Oncotarget; 2015 Jun; 6(16):14596-613. PubMed ID: 25999349
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of alkylphospholipid edelfosine in prostate cancer models and endoplasmic reticulum targeting.
Dakir EH; Gajate C; Mollinedo F
Biomed Pharmacother; 2023 Nov; 167():115436. PubMed ID: 37683591
[TBL] [Abstract][Full Text] [Related]
12. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum.
Gajate C; Matos-da-Silva M; Dakir el-H; Fonteriz RI; Alvarez J; Mollinedo F
Oncogene; 2012 May; 31(21):2627-39. PubMed ID: 22056873
[TBL] [Abstract][Full Text] [Related]
13. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast.
Cuesta-Marbán Á; Botet J; Czyz O; Cacharro LM; Gajate C; Hornillos V; Delgado J; Zhang H; Amat-Guerri F; Acuña AU; McMaster CR; Revuelta JL; Zaremberg V; Mollinedo F
J Biol Chem; 2013 Mar; 288(12):8405-8418. PubMed ID: 23335509
[TBL] [Abstract][Full Text] [Related]
14. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
15. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition.
Gajate C; Gayet O; Fraunhoffer NA; Iovanna J; Dusetti N; Mollinedo F
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885233
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells.
Melo-Lima S; Lopes MC; Mollinedo F
Pharmacol Res; 2015; 95-96():2-11. PubMed ID: 25749008
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells.
Nieto-Miguel T; Fonteriz RI; Vay L; Gajate C; López-Hernández S; Mollinedo F
Cancer Res; 2007 Nov; 67(21):10368-78. PubMed ID: 17974980
[TBL] [Abstract][Full Text] [Related]
18. The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway.
Lim SC; Parajuli KR; Han SI
Tumour Biol; 2016 May; 37(5):6205-16. PubMed ID: 26615420
[TBL] [Abstract][Full Text] [Related]
19. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]